Showing results (1-10 of 240) with videos related to

Sort By:
Pageof 24
Psychiatry and Clinical Neurosciences|January 21, 2015
Psychotropic dose equivalence in JapanToshiya Inada, Ataru Inagaki
Human Psychopharmacology|August 19, 2003
Efficacy of diazepam as an anti-anxiety agent: meta-analysis of double-blind, randomized controlled trials carried out in JapanToshiya Inada, Shoko Nozaki, Ataru Inagaki, et al.
Human Psychopharmacology|June 17, 2011
The inter-rater reliability of the Japanese version of the Inventory of Depressive Symptomatology, clinician versionNobutomo Yamamoto, Sachiko Kawakami, Koichi Sato, et al.
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|November 4, 2015
[Individually Safe and Realistic Correction of Antipsychotic Polypharmacy and High-dose Regimens in Japanese Patients with Chronic Schizophrenia: The SCAP method]Yoshio Yamanouchi, Tsuruhei Sukegawa, Ataru Inagaki, et al.
BMC Medical Research Methodology|April 30, 2002
Are the cochrane group registers comprehensive? A case study of Japanese psychiatry trialsToshi A Furukawa, Toshiya Inada, Clive E Adams, et al.
BMC Psychiatry|April 9, 2014
Study protocol: safety correction of high dose antipsychotic polypharmacy in JapanTsuruhei Sukegawa, Ataru Inagaki, Yoshio Yamanouchi, et al.
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|January 9, 2019
[Safety of Long-acting Injectable Antipsychotics Is Long-acting Injection a High-risk Treatment Option?]Ataru Inagaki
Human Psychopharmacology|January 18, 2012
Prescription profiles for pharmacological treatment of Japanese inpatients with schizophrenia: comparison between 2007 and 2009Takashi Yoshio, Toshiya Inada, Junji Uno, et al.
Brain and Nerve = Shinkei Kenkyu No Shinpo|December 29, 2017
[Drug-Induced Akathisia]Toshiya Inada
Pageof 24